Peng S - Search Results

1

Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.

Hei N, Chen Y, Peng S, Bao Y, Jin L. Hei N, et al. Among authors: peng s. Arch Oral Biol. 2022 Dec;144:105567. doi: 10.1016/j.archoralbio.2022.105567. Epub 2022 Oct 4. Arch Oral Biol. 2022. PMID: 36265392

2

A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.

Chen Y, Hei N, Zhao J, Peng S, Yang K, Chen H, Cui Z, Jin L, Sun R, Guo J. Chen Y, et al. Among authors: peng s. J Cell Biochem. 2019 Jun;120(6):9082-9090. doi: 10.1002/jcb.28182. Epub 2018 Dec 12. J Cell Biochem. 2019. PMID: 30548666

3

Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma: research includes bioinformatics analysis and experiments.

Jie G, Peng S, Cui Z, He C, Feng X, Yang K. Jie G, et al. Among authors: peng s. BMC Oral Health. 2022 May 6;22(1):160. doi: 10.1186/s12903-022-02203-4. BMC Oral Health. 2022. PMID: 35524329 Free PMC article.

4

Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.

Yang K, Niu Y, Cui Z, Jin L, Peng S, Dong Z. Yang K, et al. Among authors: peng s. Mol Carcinog. 2022 Sep;61(9):865-875. doi: 10.1002/mc.23438. Epub 2022 Jun 22. Mol Carcinog. 2022. PMID: 35730908

5

Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression.

Hei N, Liu P, Jin L, Peng S, Bao Y. Hei N, et al. Among authors: peng s. Funct Integr Genomics. 2023 Jan 31;23(1):52. doi: 10.1007/s10142-023-00973-w. Funct Integr Genomics. 2023. PMID: 36717528

6

The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.

Xia Y, Hei N, Peng S, Cui Z. Xia Y, et al. Among authors: peng s. Head Neck. 2023 Sep;45(9):2424-2437. doi: 10.1002/hed.27442. Epub 2023 Jun 28. Head Neck. 2023. PMID: 37377048

7

ECT2 promotes the occurrence and is a prognostic biomarker of head and neck squamous cell carcinoma.

Peng S, Wang J, Hei N, Cui Z. Peng S, et al. J Cancer. 2024 Jun 3;15(13):4156-4174. doi: 10.7150/jca.95515. eCollection 2024. J Cancer. 2024. PMID: 38947403 Free PMC article.

8

E2F1 Promotes the Occurrence of Head and Neck Squamous Cell Carcinoma and Serves as a Prognostic Biomarker.

Wang J, Cui Z, Hei N, Yang Q, Peng S. Wang J, et al. Among authors: peng s. Appl Biochem Biotechnol. 2024 Nov 20. doi: 10.1007/s12010-024-05097-w. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 39565537

9

The surgical safety margin after neoadjuvant chemotherapy combined with nimotuzumab leading to tumor regression.

Zhang S, Chen S, Chai G, Shi Y, Bao Y, Peng S, Cui Z, Hao J. Zhang S, et al. Among authors: peng s. J Chin Med Assoc. 2024 Dec 23. doi: 10.1097/JCMA.0000000000001199. Online ahead of print. J Chin Med Assoc. 2024. PMID: 39710865

10

Integrating single-cell RNA-seq and bulk RNA-seq to construct a neutrophil prognostic model for predicting prognosis and immune response in oral squamous cell carcinoma.

Wang J, Cui Z, Song Q, Yang K, Chen Y, Peng S. Wang J, et al. Among authors: peng s. Hum Genomics. 2024 Dec 26;18(1):140. doi: 10.1186/s40246-024-00712-7. Hum Genomics. 2024. PMID: 39726033 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,045 results

Search Page

Filters